Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
J Orthop Surg Res. 2020 Dec 7;15(1):588. doi: 10.1186/s13018-020-02133-3.
At present, the choice of surgical approach for both-column fractures is still controversial. The purpose of this study was to explore the efficacy of the Stoppa combined with iliac fossa (S+IF) approach in the treatment of both-column fractures.
In this retrospective case series, 76 patients were included in the study from 2014 to 2018. They were divided into two groups according to the surgical approaches. The differences of intraoperative blood loss, operative time, quality of reduction, clinical outcome, and perioperative complications were compared between the two groups.
All patients had undergone the IL approach or the S+IF approach. The average operative time was 156.2 min (110210 min) in group I and 126.5 min (80180 min) in group II (P < 0.001). The average blood loss in group I was 784.1 ml, while the average blood loss in group II was 625.3 ml (P = 0.007). According to Matta's criteria, 28 cases obtained anatomic reduction and 12 cases got imperfect reduction in group I; 21 cases obtained anatomic reduction and 7 cases got imperfect reduction in group II (P > 0.05). The clinical outcome (excellent to good) was 66% in group I versus 69% in group II (P > 0.05). The complication rates were 18.2% in group I and 12.5% in group II (P > 0.05).
As a minimally invasive surgical approach, the S+IF approach is a valuable alternative to the IL approach for the treatment of both-column acetabular fractures if these two anterior approaches can achieve fracture exposure, reduction, and fixation.
目前,对于双柱骨折的手术入路选择仍存在争议。本研究旨在探讨 Stoppa 联合髂腹股沟入路(S+IF)治疗双柱骨折的疗效。
本回顾性病例系列研究纳入 2014 年至 2018 年期间的 76 例患者,根据手术入路将其分为两组。比较两组患者术中出血量、手术时间、复位质量、临床疗效和围手术期并发症的差异。
所有患者均接受了 IL 入路或 S+IF 入路。组 I 的平均手术时间为 156.2 分钟(110210 分钟),组 II 的平均手术时间为 126.5 分钟(80180 分钟)(P < 0.001)。组 I 的平均出血量为 784.1ml,组 II 的平均出血量为 625.3ml(P = 0.007)。根据 Matta 标准,组 I 中有 28 例获得解剖复位,12 例获得不完美复位;组 II 中有 21 例获得解剖复位,7 例获得不完美复位(P > 0.05)。组 I 的临床疗效(优至良)为 66%,组 II 的临床疗效为 69%(P > 0.05)。组 I 的并发症发生率为 18.2%,组 II 的并发症发生率为 12.5%(P > 0.05)。
S+IF 入路作为一种微创入路,如果这两种前入路能够实现骨折暴露、复位和固定,那么它是治疗双柱髋臼骨折的一种有价值的替代 IL 入路。